Venture Capital, Artificial Intelligence, Startup, Biotechnology, London.
will give us the ability to engineer proteins with both enhanced and entirely novel functionality. You raised $3.66m seed funding last year. Tell us more about who was involved with this. Our seed funding has massively accelerated the team’s work. In a few short months, we’ve been able to build our